The periodical about the pharmaceutical and medical equipment markets
(Russian pharmacies) - specialized periodical edition for pgarmacy professionals
Medical Council - Scientific Journal for Physicians
Oasmia Pharmaceutical AB announced today that its lead cancer product Paclical received market authorization in the Russian Federation by the Russian Ministry of Health. Paclical is the first water-soluble cancer drug with paclitaxel to receive a market authorization. Oasmia plans to launch the product in the third quarter of 2015.
Novo Nordisk has opened a new manufacturing facility in the Kaluga region of Russia for formulation and filling of modern insulin for the treatment of diabetes.
The Orel Region governor Vadim Potomsky presented the industrial and investment potential of the subject in the French Embassy. The authorities of the region are sure that the regime of sanctions won’t prevent development of bilateral relations.
Green Cross announced that it signed an agreement of strategic partnership with Nanolek, Russian pharmaceutical company to commercialize the biopharmaceutical products of Green Cross.
1 - 5 из 775
The cost of medicine is rising fast in Russia, hitting consumers and challenging a government that has made its reputation as a bulwark of social stability.
Начало | Пред. |
programmer of electronic software products